Oncolytics Biotech Inc (ONCY)
1.17
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.17
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Max Drawdown (5Y): 96.21% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.21% |
March 31, 2024 | 96.21% |
February 29, 2024 | 96.21% |
January 31, 2024 | 96.21% |
December 31, 2023 | 96.21% |
November 30, 2023 | 96.21% |
October 31, 2023 | 96.21% |
September 30, 2023 | 96.21% |
August 31, 2023 | 96.21% |
July 31, 2023 | 96.21% |
June 30, 2023 | 96.21% |
May 31, 2023 | 96.21% |
April 30, 2023 | 96.21% |
March 31, 2023 | 96.21% |
February 28, 2023 | 98.32% |
January 31, 2023 | 98.36% |
December 31, 2022 | 98.36% |
November 30, 2022 | 98.36% |
October 31, 2022 | 98.36% |
September 30, 2022 | 98.36% |
August 31, 2022 | 98.36% |
July 31, 2022 | 98.36% |
June 30, 2022 | 98.36% |
May 31, 2022 | 98.36% |
April 30, 2022 | 98.36% |
Date | Value |
---|---|
March 31, 2022 | 98.36% |
February 28, 2022 | 98.36% |
January 31, 2022 | 98.36% |
December 31, 2021 | 98.36% |
November 30, 2021 | 98.36% |
October 31, 2021 | 98.36% |
September 30, 2021 | 98.36% |
August 31, 2021 | 98.36% |
July 31, 2021 | 98.36% |
June 30, 2021 | 98.36% |
May 31, 2021 | 98.36% |
April 30, 2021 | 98.36% |
March 31, 2021 | 98.36% |
February 28, 2021 | 98.36% |
January 31, 2021 | 98.36% |
December 31, 2020 | 98.36% |
November 30, 2020 | 98.36% |
October 31, 2020 | 98.36% |
September 30, 2020 | 98.36% |
August 31, 2020 | 98.36% |
July 31, 2020 | 98.36% |
June 30, 2020 | 98.36% |
May 31, 2020 | 98.36% |
April 30, 2020 | 98.36% |
March 31, 2020 | 98.36% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.21%
Minimum
Mar 2023
98.36%
Maximum
May 2019
97.86%
Average
98.36%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -33.63 |
Beta (5Y) | 1.910 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 137.7% |
Historical Sharpe Ratio (5Y) | -0.0896 |
Historical Sortino (5Y) | -0.2855 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.88% |